Fishawack research: COVID-19 has accelerated the pace of industry innovation and change
Fishawack Health has conducted original research on the impact of the COVID-19 pandemic on the life sciences industry, read our interview with MM&M.
The global pandemic has led to disruption in the industry. A new study conducted by strategic consultants at Fishawack Health confirms this and reveals that the disruption has led to an accelerated rate of change within the industry.
“The pandemic is going to change every single care pathway in some way, whether it’s drugs and treatments that are administered or the way the patient is diagnosed or remotely monitored,” explains Fishawack Health’s Head of Consulting, Fred Basset.
Read the full interview to uncover exclusive insights on the emerging implications of COVID-19 on the healthcare industry on MM&M.